Sujit Sansgiry

Sujit Sansgiry serves as Professor in the Department of Pharmaceutical Health Outcomes and Policy at the University of Houston College of Pharmacy, where he conducts innovative research to advance human health science and improve pharmaceutical outcomes through evidence-based interventions.

His educational credentials include:

• Post-doctoral Pharmacoeconomic Research Fellowship at RxAmerica/Novartis
• PhD in Pharmaceutical Sciences (Pharmacy Administration), Idaho State University
• MS in Pharmacy (Pharmacy Administration), Idaho State University
• Bachelor of Pharmaceutical Sciences, University of Bombay

Dr. Sansgiry's research program spans pharmaceutical outcomes, pharmacoeconomics, and pharmacy education, with emphasis on medication adherence, chronic disease management (COPD, diabetes, asthma), and academic progress evaluation. His work develops strategies to enhance learning methodologies and assesses interventions for improving health outcomes in vulnerable populations, particularly Medicare beneficiaries and pharmacy students.

Analysis of his recent publications reveals strong thematic clusters in pharmacy education (student mental health, admissions processes) and health outcomes (COPD exacerbation, opioid use, diabetic complications). Notably, he integrates machine learning for predicting diabetes complications and examines policy impacts like Medicare coverage gaps and hydrocodone rescheduling on prescribing behavior.

His exceptional contributions are recognized through:

• Three-time recipient of Rho Chi Teaching Excellence Award (2021-2022, 2017-2018, 2013-2014)
• Multiple Best Poster Awards at ISPOR, AMCP, and Health Services Research Conferences (2010-2018)
• PhRMA Foundation Research Starter Grant in Adherence Improvement (2015)

Dr. Sansgiry has secured competitive external funding including the PhRMA grant and mentors students through research projects on admissions processes and health outcomes. His work directly informs healthcare policy and pharmacy practice innovations, with significant implications for academic pharmacy curriculum development and medication therapy management.